# AstraZeneca urged to avoid $400bn US mega-merger, stick with strategy

A Guardian analysis argues AstraZeneca does not need a $400bn US mega-merger to succeed, urging the company to stay with its current winning formula. The piece suggests pursuing such a deal could introduce risk and distraction, despite pressure for scale in the pharma sector.

**Importance:** 3/5

## Sources

### Business
- [The Guardian Biz](https://www.theguardian.com/business/2026/aug/03/astrazeneca-should-stick-to-winning-formula-doesnt-need-400bn-us-mega-merger) — Mon, 03 Aug 2026 17:22:28 GMT